Children's Ibuprofen Oral Suspension
Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.
Yes — there is an active recall. 15 ongoing FDA recalls mention Ibuprofen (68 total). Check the affected lots below.
Most common reason: cGMP deviation (21 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Ibuprofen. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations
Failed Tablet/Capsule Specifications
Failed Impurities/Degradation Specifications: Product failed impurity specifications at the 18-month stability testing.
Failed Impurities/Degradation Specifications - at 18-month Stability testing
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
Presence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle of Ibuprofen and Famotidine.
CGMP deviation: product outside labeled storage temperature requirements.
CGMP deviation: product outside labeled storage temperature requirements.
CGMP deviation: product outside labeled storage temperature requirements.
CGMP deviation: product outside labeled storage temperature requirements.
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
CGMP Deviations: product held outside appropriate storage temperature conditions.
cGMP deviations: Temperature abuse
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Labeling Not Elsewhere Classified: Ibuprofen Oral Suspension is missing dosing cups.
Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.
Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.
Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.
Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.